In-hospital management and outcome of patients on warfarin undergoing coronary stent implantation: Results of the multicenter, prospective WARfarin and coronary STENTing (WAR-STENT) registry

Journal of Invasive Cardiology

Volumn 25, Issue 4, 2013, Pages 170-176

  Rubboli, Andrea ^a   Sciahbasi, Alessandro ^b   Briguori, Carlo ^c   Saia, Francesco ^d   Palmieri, Cataldo ^e   Moroni, Luigi Andrea ^f   Calabrò, Paolo ^g   Leone, Antonio Maria ^b   Franco, Nicoletta ^h   Valgimigli, Marco ⁱ   Varani, Elisabetta ^j   Santi, Michela ^k   Pasqualini, Paola ^l   Capecchi, Alessandro ^k   Piccalò, Giacomo ^m   Margheri, Massimo ^j   Di Pasquale, Giuseppe ^a   Galvani, Marcello ⁿ   Bolognese, Leonardo ^o   Gonzini, Lucio ^p   Maggioni, Aldo Pietro ^p   more..

^a MAGGIORE HOSPITAL   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^c Clinica Mediterranea   (Italy)

^d Ospedale Universitario   (Italy)

^e G PASQUINUCCI HOSPITAL   (Italy)

^f VILLA SCASSI HOSPITAL   (Italy)

^g MONALDI HOSPITAL   (Italy)

^h OSPEDALE DEGLI INFERMI   (Italy)

ⁱ UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^j SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

^k Ospedale Civile   (Italy)

^l MISERICORDIA HOSPITAL   (Italy)

^m OSPEDALE NIGUARDA CA GRANDA   (Italy)

ⁿ MORGAGNI PIERANTONI HOSPITAL   (Italy)

^o IRCCS POLICLINICO SAN DONATO   (Italy)

^p ANMCO RESEARCH CENTER   (Italy)

more..

Author keywords

antiplatelet drugs; oral anticoagulation; percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; WARFARIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANTICOAGULATION; ARTICLE; BARE METAL STENT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; FAMILY HISTORY; FEMALE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITAL DISCHARGE; HOSPITAL MANAGEMENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRESCRIPTION; PROSPECTIVE STUDY; ST SEGMENT ELEVATION; THROMBOEMBOLISM; VENOUS THROMBOEMBOLISM;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; DISEASE MANAGEMENT; DRUG-ELUTING STENTS; FEMALE; HUMANS; INCIDENCE; INPATIENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; STROKE; THROMBOEMBOLISM; WARFARIN;

EID: 84875989882     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Lip GY, Huber K, Andreotti F, et al European Society of Cardiology Working Group on Thrombosis. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting. Thromb Haemost. 2010;103(1):13-28.
2. Faxon DP, Eikelboom JW, Berger PB, et al. Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North American perspective. Thromb Haemost. 2011;106(4):572-584.
3. Rubboli A, Halperin JL, Airaksinen KE, et al. Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation. Ann Med. 2008;40(6):428-436.
4. Karjalainen PP, Porela P, Ylitalo A, et al. Safety and efficacy of combined anti-platelet warfarin therapy after coronary stenting. Eur Heart J. 2007;28(6):726-732.
5. Gilard M, Blanchard D, Helft G, et al STENTICO Investigators. Antiplatelet therapy in patients with anticoagulants undergoing percutaneous coronary stenting (from STENTIng and oral antiCOagulants [STENTICO]). Am J Cardiol. 2009;104(3):338-342.
6. Hälg C, Brunner-La Rocca HP, Kaiser C, et al; BASKET Investigators. Early and late increased bleeding rates after angioplasty and stenting due to combined antiplatelet and anticoagulant therapy. Eurointervention. 2009;5(4):425-431.
7. Nikolsky E, Mehran R, Dangas GD, et al. Outcomes of patients treated with triple antithrombotic therapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction (from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Trial). Am J Cardiol. 2012;109(6):831-838.
8. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Circulation. 2007;116(22):2634-2653.
9. Cutlip DE, Windecker S, Mehran R, et al Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115(17):2344-2351.
10. Bovill EG, Terrin ML, Stump DC, et al. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction: results of the Thrombolysis In Myocardial Infarction (TIMI), phase II trial. Ann Intern Med. 1991;115(4):256-265.
11. Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369-2429.
12. You JJ, Singer DE, Howard PA, et al American College of Chest Physicians. Antithrombotic therapy for atrial fibrillation. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(Suppl):531S-575S.
13. Rubboli A, Colletta M, Valencia J, et al WARfarin and Coronary STENTing (WAR-STENT) Study Group. Periprocedural management and in-hospital outcome of patients with indication for oral anticoagulation undergoing coronary artery stenting. J Intervent Cardiol. 2009;22(4):390-397.
14. Lahtela H, Rubboli A, Schlitt A, et al AFCAS (Management of patients with Atrial Fibrillation undergoing Coronary Artery Stenting) Study Group. Heparin bridging vs. uninterrupted oral anticoagulation in patients with atrial fibrillation undergoing coronary artery stenting. Results from the AFCAS registry. Circ J. 2012;76(6):1363-1368.
15. Silber S, Albertsson P, Avilès FF, et al Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the European Society of Cardiology. Eur Heart J. 2005;26(8):804-847.
16. Rubboli A, Dewilde W, Huber K, et al. The management of patients on oral anticoagulation undergoing coronary stent implantation: a survey among interventional cardiologists from eight European countries. J Interv Cardiol. 2012;25(2):163-169.
17. Kiviniemi T, Karjalainen P, Pietilä M, et al. Comparison of additional versus no additional heparin during therapeutic oral anticoagulation in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2012;110(1):30-35.
18. Verheugt FWA, Steinhubl SR, Hamon M, et al. Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention. JACC Cardiovasc Interv. 2011;4(2):191-197.